Voluntary announcement - voluntary lock-up undertaking by directors and senior management
Filed with HKEX · Stock code 9606 · · 2 pages · English
Summary by 6ix AI
Duality Biotherapeutics, Inc. has made a voluntary announcement regarding a lock-up undertaking by its directors and senior management. The undertaking prevents these individuals from selling or disposing of their shares for a specified period, reflecting their confidence in the company's future. The announcement includes the names and positions of the directors and senior management involved in this commitment. Shareholders and potential investors are advised to exercise caution when trading the company's securities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/voluntary-announcement-voluntary-lock-up-undertaking-by-directors-and-senior-management
Duality Biotherapeutics, Inc. on 6ix
Earlier from Duality Biotherapeutics
- Voluntary announcement - update on share repurchases and proposed increase in shareholding by chairman of the board
- Next Day Disclosure Return
- Inside information - update on the dynasty-BREAST02 global Phase 3 clinical trial of trastuzumab pamirtecan
- An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Later from Duality Biotherapeutics
All Duality Biotherapeutics news releasesFollow Duality Biotherapeutics into a list and get an email when it puts out news.
Follow Duality Biotherapeutics